Concepedia

Maarten van den Boer

MV

Statistics

Publications

4

Citations

172

H-Index

4

Active since

2018

Affiliations

Janssen (Belgium)(Current)

Janssen (United States)

Maarten van den Boer is an author at Janssen (Belgium) specializing in medicine, hepatitis b, and viral hepatitis.

Top concepts

Publications per year

2018–2020

4

Publications

4

Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants

Maarten Timmers, Paulien Ravenstijn, Liwen Xi et al. · Journal of Psychopharmacology · 2018 · 62 citations

Fatty Acid Amide Hydrolase Inhibition by JNJ‐42165279: A Multiple‐Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers

Andrey Postnov, Mark E. Schmidt, Darrel J. Pemberton et al. · Clinical and Translational Science · 2018 · 46 citations · Full text

The first‐in‐human study of CNTO 7160, an anti‐interleukin‐33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis

Ivo Nnane, Bart Frederick, Zhenling Yao et al. · British Journal of Clinical Pharmacology · 2020 · 36 citations · Full text

Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects

Joris Vandenbossche, Wolfgang Jessner, Maarten van den Boer et al. · Advances in Therapy · 2019 · 28 citations

, , +8

1–4 of 4